{"id":34647,"date":"2024-11-26T17:05:54","date_gmt":"2024-11-26T17:05:54","guid":{"rendered":"https:\/\/bnssghealthiertogether.org.uk\/?page_id=34647"},"modified":"2024-11-26T17:05:54","modified_gmt":"2024-11-26T17:05:54","slug":"how-can-we-identify-and-support-children-with-life-limiting-conditions-with-complex-polypharmacy-the-polypill-project","status":"publish","type":"page","link":"https:\/\/bnssghealthiertogether.org.uk\/sq\/integrated-care-board\/research-and-evidence\/our-research-portfolio\/type-2-rcf-funded-projects\/how-can-we-identify-and-support-children-with-life-limiting-conditions-with-complex-polypharmacy-the-polypill-project\/","title":{"rendered":"Si mund t\u2019i identifikojm\u00eb dhe mb\u00ebshtesim f\u00ebmij\u00ebt me gjendje kufizuese t\u00eb jet\u00ebs me polifarmaci komplekse? \u2013 projekti PolyPiLL"},"content":{"rendered":"
Seksioni me titull module-1<\/span><\/a>
\r\n
\r\n

Si mund t\u2019i identifikojm\u00eb dhe mb\u00ebshtesim f\u00ebmij\u00ebt me gjendje kufizuese t\u00eb jet\u00ebs me polifarmaci komplekse? \u2013 projekti PolyPiLL<\/h1>\n

Financimi<\/h2>\n

Financimi i Aft\u00ebsive K\u00ebrkimore t\u00eb BNSSG ICB.<\/p>\n

Cila \u00ebsht\u00eb pyetja k\u00ebrkimore?<\/h2>\n

Si mund t\u2019i identifikojm\u00eb dhe mb\u00ebshtesim f\u00ebmij\u00ebt me gjendje kufizuese t\u00eb jet\u00ebs me polifarmaci komplekse?<\/p>\n

Cili \u00ebsht\u00eb problemi?<\/h2>\n

Shum\u00eb f\u00ebmij\u00eb me nevoja komplekse ose gjendje kufizuese t\u00eb jet\u00ebs k\u00ebrkojn\u00eb medikamente t\u00eb shum\u00ebfishta (polifarmaci), shpesh p\u00ebr periudha t\u00eb gjata, duke ngritur shqet\u00ebsime n\u00eb lidhje me sigurin\u00eb e pacientit. Prind\u00ebrve\/kujdestar\u00ebve shpesh u k\u00ebrkohet t\u00eb koordinojn\u00eb nj\u00eb regjim t\u00eb nd\u00ebrlikuar administrimi dhe komunikim t\u00eb gjer\u00eb me profesionist\u00eb t\u00eb shumt\u00eb t\u00eb kujdesit sh\u00ebndet\u00ebsor n\u00eb nj\u00eb s\u00ebr\u00eb mjedisesh, duke rritur k\u00ebrkesat p\u00ebr koh\u00ebn e tyre. P\u00ebrshkrimi dhe furnizimi me medikamente mund t\u00eb jet\u00eb p\u00ebrgjegj\u00ebsi e disa ofruesve t\u00eb ve\u00e7ant\u00eb t\u00eb kujdesit sh\u00ebndet\u00ebsor (mjek\u00eb t\u00eb p\u00ebrgjithsh\u00ebm, specialist\u00eb pediatrik\u00eb, farmaci komunitare ose spitalore) me pak mbik\u00ebqyrje kolektive.<\/p>\n

Iniciativat komb\u00ebtare dhe nd\u00ebrkomb\u00ebtare n\u00eb lidhje me polifarmacin\u00eb synojn\u00eb p\u00ebrmir\u00ebsimin e siguris\u00eb s\u00eb menaxhimit t\u00eb barnave p\u00ebr t\u00eb gjith\u00eb. Nd\u00ebrsa polifarmacia dhe problemet q\u00eb ajo krijon p\u00ebr pacient\u00ebt dhe profesionist\u00ebt e kujdesit sh\u00ebndet\u00ebsor kan\u00eb qen\u00eb n\u00eb qend\u00ebr t\u00eb k\u00ebrkimit dhe iniciativave t\u00eb p\u00ebrmir\u00ebsimit p\u00ebr pacient\u00ebt e rritur, pak dihet p\u00ebr ndikimin e polifarmacis\u00eb tek f\u00ebmij\u00ebt me s\u00ebmundje q\u00eb kufizojn\u00eb jet\u00ebn, familjet\/kujdestar\u00ebt e tyre, ose se si t'i mb\u00ebshtesim ata m\u00eb mir\u00eb.<\/p>\n

Cili \u00ebsht\u00eb q\u00ebllimi i hulumtimit?<\/h2>\n

Ky hulumtim do t\u00eb p\u00ebrmir\u00ebsoj\u00eb kuptimin ton\u00eb t\u00eb \u00e7\u00ebshtjeve t\u00eb ngritura nga polifarmacia p\u00ebr f\u00ebmij\u00ebt dhe t\u00eb rinjt\u00eb me gjendje kufizuese t\u00eb jet\u00ebs. N\u00eb shum\u00eb raste, f\u00ebmij\u00ebt me gjendje kufizuese t\u00eb jet\u00ebs nuk mund ta shmangin nevoj\u00ebn p\u00ebr medikamente t\u00eb shum\u00ebfishta, prandaj q\u00ebllimi i k\u00ebtij hulumtimi \u00ebsht\u00eb t\u00eb eksploroj\u00eb se si t\u00eb minimizohet d\u00ebmi i panevojsh\u00ebm p\u00ebr pacientin dhe t\u00eb thjeshtohet procesi i menaxhimit t\u00eb ila\u00e7eve p\u00ebr prind\u00ebrit\/kujdestar\u00ebt. Ky kuptim i p\u00ebrvoj\u00ebs s\u00eb pacientit dhe familjes, i kombinuar me kontributin e koleg\u00ebve klinik\u00eb, do t\u00eb mb\u00ebshtes\u00eb zhvillimin e nj\u00eb procesi p\u00ebr t\u00eb identifikuar dhe mb\u00ebshtetur ata me polifarmaci komplekse ose problematike n\u00eb nj\u00eb m\u00ebnyr\u00eb t\u00eb p\u00ebrqendruar te personi.<\/p>\n

Edhe pse p\u00ebrtej fush\u00ebveprimit t\u00eb k\u00ebtij aplikimi p\u00ebr financim RCF-2, n\u00eb fund t\u00eb fundit kjo qasje do t\u00eb siguronte q\u00eb \u00e7do kontribut i farmacistit specialist ose klinik p\u00ebr t\u00eb p\u00ebrmir\u00ebsuar sigurin\u00eb e pacientit dhe p\u00ebr t\u00eb mb\u00ebshtetur f\u00ebmij\u00ebt dhe familjet n\u00eb sht\u00ebpi t\u00eb drejtohej tek ata q\u00eb kan\u00eb m\u00eb shum\u00eb nevoj\u00eb, dhe q\u00eb rezultatet e nj\u00eb nd\u00ebrhyrjeje t\u00eb mund t\u00eb ishin t\u00eb matshme. Vler\u00ebsimi i k\u00ebtyre nd\u00ebrhyrjeve t\u00eb specializuara dhe t\u00eb synuara do t\u00eb ishte objekt i nj\u00eb aplikimi p\u00ebr financim nga NIHR RfPB n\u00eb koh\u00ebn e duhur.<\/p>\n

Si do t\u00eb arrihet kjo?<\/h2>\n

Ky studim do t\u00eb p\u00ebrb\u00ebhet nga tre faza, duke filluar me nj\u00eb rishikim t\u00eb literatur\u00ebs i cili do t\u00eb p\u00ebrqendrohet n\u00eb identifikimin e polifarmacis\u00eb komplekse dhe nd\u00ebrhyrjet p\u00ebr t\u00eb minimizuar rrezikun e pacientit dhe barr\u00ebn e kujdestarit.<\/p>\n

N\u00eb faz\u00ebn e dyt\u00eb, intervistat me f\u00ebmij\u00ebt\/t\u00eb rinjt\u00eb dhe prind\u00ebrit e tyre do t\u00eb ofrojn\u00eb prova cil\u00ebsore rreth nevojave dhe shqet\u00ebsimeve t\u00eb tyre n\u00eb lidhje me menaxhimin e medikamenteve t\u00eb tyre. Kjo do t\u00eb plot\u00ebsohet me intervista me stafin klinik (mjek\u00eb t\u00eb f\u00ebmij\u00ebve, infermier\u00eb, farmacist\u00eb) rreth m\u00ebnyr\u00ebs se si ata e identifikojn\u00eb polifarmacin\u00eb komplekse ose problematike dhe \u00e7far\u00eb do t\u00eb sinjalizonte nevoj\u00ebn p\u00ebr mb\u00ebshtetje shtes\u00eb p\u00ebr familjet.<\/p>\n

N\u00eb faz\u00ebn e tret\u00eb, gjetjet nga fazat 1 dhe 2 do t\u00eb ndahen me pal\u00ebt e interesuara n\u00eb nj\u00eb ngjarje konsensusi. Pal\u00ebt e interesuara do t\u00eb p\u00ebrfshijn\u00eb pacient\u00ebt dhe familjet, klinicist\u00ebt nga nj\u00eb s\u00ebr\u00eb mjedisesh dhe prejardhjesh, si dhe komisioner\u00ebt. Rezultatet e k\u00ebsaj do t\u00eb \u00e7ojn\u00eb n\u00eb bashk\u00eb-krijimin e nj\u00eb mjeti p\u00ebr t\u00eb identifikuar polifarmacin\u00eb komplekse ose problematike, si dhe n\u00eb sugjerime p\u00ebr mb\u00ebshtetje profesionale p\u00ebr t\u00eb p\u00ebrmir\u00ebsuar menaxhimin e sigurt, efikas dhe efektiv t\u00eb barnave.<\/p>\n

Kush po e udh\u00ebheq hulumtimin?<\/h2>\n

Dr. Nicky Harris, Bashk\u00ebpun\u00ebtore K\u00ebrkimore, Qendra p\u00ebr Sh\u00ebndet\u00ebsi dhe K\u00ebrkime Klinike UWE<\/p>\n

Informacione t\u00eb m\u00ebtejshme:<\/h2>\n

P\u00ebr m\u00eb shum\u00eb informacion ose p\u00ebr t'u p\u00ebrfshir\u00eb n\u00eb k\u00ebt\u00eb projekt, ju lutemi kontaktoni bnssg.research@nhs.net<\/p>\n <\/div>\r\n <\/section><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Section titled module-1 How can we identify and support children with life-limiting conditions with complex polypharmacy? \u2013 the PolyPiLL project Funding BNSSG ICB Research Capability Funding. What is the research question? How can we identify and support children with life-limiting conditions with complex polypharmacy? What is the problem? Many children with complex needs or life-limiting […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":32896,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"tags":[],"class_list":["post-34647","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/34647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/comments?post=34647"}],"version-history":[{"count":2,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/34647\/revisions"}],"predecessor-version":[{"id":34649,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/34647\/revisions\/34649"}],"up":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/32896"}],"wp:attachment":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/media?parent=34647"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/tags?post=34647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}